Published • loading... • Updated
MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring
- MGI Tech Co., Ltd. has partnered with Eva Holding Group to develop Brazil's genetic sector by enhancing disease monitoring and access to genomics for patients in Brazil.
- The partnership will install genetic sequencers, including the DNBSEQ-T7, to improve cancer tracking accuracy.
- The DNBSEQ-T7 is the first IVD-certified high-throughput equipment in Brazil, enabling clinical use of cutting-edge technology for the first time.
- Dr. Rene Pimenta da Silva Junior and Dr. Carolina A. Barbosa emphasized that this collaboration will significantly impact oncology patients through innovative genomic approaches.
Insights by Ground AI
77 Articles
77 Articles
MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring
SÃO PAULO, Oct. 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian…
Coverage Details
Total News Sources77
Leaning Left9Leaning Right9Center24Last UpdatedBias Distribution57% Center
Bias Distribution
- 57% of the sources are Center
57% Center
L 22%
C 57%
R 21%
Factuality
To view factuality data please Upgrade to Premium



















